Medicines List

Select category
  • Description

    Spironolacton-Tchaikapharma stimulates the excretion of urine in patients who have fluid accumulation in the tissues (edema) or in the abdominal cavity (ascites) by increasing the amount of sodium (salt) excreted in the urine.


    Spironolacton-Tchaikapharma is indicated for the treatment of:
    – congestive cardiac failure;
    – hepatic cirrhosis with ascites and oedema;
    – malignant ascites;
    – nephrotic syndrome;
    – diagnosis and treatment of primary aldosteronism (syndrom of Conn);
    – hypertension in combination with other antihypertensive products, especially when prone to hypokalaemia.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 25 mg, 50 mg, 100 mg film-coated tablets

    Patient information leaflet

  • Description

    Topiramate is an antiepilepsy drug.


    –  Monotherapy in adults, adolescents and children over 6 years of age with partial seizures with or without secondary generalised seizures, and primary generalised tonic-clonic seizures.

    –  Adjunctive therapy in children aged 2 years and above, adolescents and adults with partial onset seizures with or without secondary generalization or primary generalized tonic-clonic seizures and for the treatment of seizures associated with Lennox-Gastaut syndrome.

    –  Topiramate is indicated in adults for the prophylaxis of migraine headache after careful evaluation of possible alternative treatment options and is not intended for acute treatment.

    Subject to medical prescription

    Pharmaceutical form: 50 mg x 30 film-coated tablets

    NHIF code: NF 675          ICD: G40.6, G40.7

    Pharmaceutical form: 100 mg x 30 film-coated tablets

    NHIF code: NF 676          ICD: G40.6, G40.7